Loading
Latest filing published 28 Nov 2025 for Immucell CORP, €6,747. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
David Scott Tomsche (board member) discloses dealings in Immucell Corp to SEC (Form 4). The record holds 12 filings, for trades running from 29 January 2016 to 25 November 2025.
The open-market record is one-sided, with 2 purchases worth €6,747 and not one sale. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2025 to date brings 1 purchase and no sales.
The newest entry dates from 28 November 2025: an open-market purchase of €6,747, in Immucell Corp. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations